EFSA Reviews Control Measures of Bluetongue
Mass vaccination programmes lasting at least five years in combination with improved, continuous surveillance systems would be the only effective measures for eradicating bluetongue in Europe, EFSA has concluded. EFSA’s experts have reviewed control measures for bluetongue and options for safe trade of animals from infected to free areas, following a request from the European Commission. They have also updated their scientific advice on epidemiological aspects of the disease, particularly its transmission patterns.
Eradication of bluetongue is very difficult – at least five consecutive years of vaccination covering 95% of susceptible cattle and sheep would be needed, the experts concluded. Such mass vaccination campaigns would have to be followed by sensitive surveillance systems capable of detecting low levels of virus prevalence, lower than 1% of animals in a monitored area. The disease could otherwise re-appear some years after completion of the vaccination campaign.
Surveillance systems should be defined on a case-by-case basis taking into account aspects such as the geographical area monitored and the epidemiological phase of the disease.
Experts also highlighted that:
- New-born animals receive antibodies from their mothers that protect them from the disease for about three months. However, these antibodies may interfere with vaccination, thus making vaccination ineffective during this period. Immunity starts in most cases 21 days after the second dose of the basic vaccination scheme.
- Some species of the midges that transmit the disease are active throughout the year – especially in mild-winter areas such as the Mediterranean basin. In these areas, transmission of the virus may occur at any time. In colder areas, such as in northern Europe, midges are inactive for about three winter months, during which transmission is halted.
In line with EFSA’s “Promoting Methods for Evidence Use” approach , EFSA’s Panel on Animal Health and Welfare captured the strategy for performing this risk assessment in a protocol that documents all the steps taken in reaching its final conclusions. This new approach enhances the robustness and transparency of the scientific process.
EFSA’s scientific advice will assist policy-makers as they review legislation on bluetongue. EFSA will classify different types of bluetongue according to their characteristics by the end of June 2017. This will help identify specific protection and control measures.
This article has been republished from materials provided by EFSA. Note: material may have been edited for length and content. For further information, please contact the cited source.
New Areas of the Brain Become Active After Students Learn PhysicsNews
Parts of the brain not traditionally associated with learning science become active when people are confronted with solving physics problems.READ MORE
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE